Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ny1972_47](/creator/twitter/ny1972_47)
"@JessieChimni Not former pharma exec not MIT grad not Wall St. fat cat. sounds great to me. $FATE is XX% lupus. Mr. Adawi also held the CFO role at Pathway Genomics as well as other financial leadership positions at Becton Dickinson GenMark Dx and Digirad Corporation"  
[X Link](https://x.com/ny1972_47/status/1978164294257610755) [@ny1972_47](/creator/x/ny1972_47) 2025-10-14T18:21Z XXX followers, XXX engagements


"@JessieChimni Talk is cheap. Which TCE Invivo CART CARNK bio etc. will be doing pivotal trial in 2026 like $FATE $CABA Mr. Gavel. With a planned first BLA submission for myositis in 2027 I look forward to drawing on my previous experience with successful CAR T launches"  
[X Link](https://x.com/ny1972_47/status/1978275557704966173) [@ny1972_47](/creator/x/ny1972_47) 2025-10-15T01:43Z XXX followers, XXX engagements


"@JessieChimni CRSP is raising cash before AID data dump ARTV is not competing with CART. FATE XXX will be the only CD19 off the shelf CART in pivot trial next year"  
[X Link](https://x.com/ny1972_47/status/1979199218636955761) [@ny1972_47](/creator/x/ny1972_47) 2025-10-17T14:54Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ny1972_47 "@JessieChimni Not former pharma exec not MIT grad not Wall St. fat cat. sounds great to me. $FATE is XX% lupus. Mr. Adawi also held the CFO role at Pathway Genomics as well as other financial leadership positions at Becton Dickinson GenMark Dx and Digirad Corporation"
X Link @ny1972_47 2025-10-14T18:21Z XXX followers, XXX engagements

"@JessieChimni Talk is cheap. Which TCE Invivo CART CARNK bio etc. will be doing pivotal trial in 2026 like $FATE $CABA Mr. Gavel. With a planned first BLA submission for myositis in 2027 I look forward to drawing on my previous experience with successful CAR T launches"
X Link @ny1972_47 2025-10-15T01:43Z XXX followers, XXX engagements

"@JessieChimni CRSP is raising cash before AID data dump ARTV is not competing with CART. FATE XXX will be the only CD19 off the shelf CART in pivot trial next year"
X Link @ny1972_47 2025-10-17T14:54Z XXX followers, XXX engagements

creator/twitter::837696479225589760/posts
/creator/twitter::837696479225589760/posts